Log in to save to my catalogue

Dual-specificity phosphatases: therapeutic targets in cancer therapy resistance

Dual-specificity phosphatases: therapeutic targets in cancer therapy resistance

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2616610060

Dual-specificity phosphatases: therapeutic targets in cancer therapy resistance

About this item

Full title

Dual-specificity phosphatases: therapeutic targets in cancer therapy resistance

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Journal of cancer research and clinical oncology, 2022-01, Vol.148 (1), p.57-70

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Purpose
Therapy resistance is the principal obstacle to achieving cures in cancer patients and its successful tackling requires a deep understanding of the resistance mediators. Increasing evidence indicates that tumor phosphatases are novel and druggable targets in translational oncology and their modulation may hinder tumor growth and motility...

Alternative Titles

Full title

Dual-specificity phosphatases: therapeutic targets in cancer therapy resistance

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2616610060

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2616610060

Other Identifiers

ISSN

0171-5216

E-ISSN

1432-1335

DOI

10.1007/s00432-021-03874-2

How to access this item